ARCHIVES

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

This article is from The Cancer Letter archive.

Vol. 28 No. 31 | August 2, 2002

Download PDF Visit The Full Archive

Related Articles

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

April 30, 2010

Cancer Control Progress, Challenge Mark ACS Observance

October 18, 1991

In Brief: Cancer Act Renewal Nears, Appropriations Bills Lag; Interim Funding Likely For ’83 Fiscal Year

September 24, 1982

PhRMA Tightens DTC Restrictions, But Dingell Says It’s Not Enough.

December 12, 2008

DCE Board Approves Recompetition Of Two Major Contracts

October 30, 1987

FDA Expands Nexavar Indication To Include Thyroid Cancer

December 27, 2013